Cite
Al-Olabi L, Polubothu S, Dowsett K, et al. Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy. J Clin Invest. 2018;128(11):5185doi: 10.1172/JCI124649.
Al-Olabi, L., Polubothu, S., Dowsett, K., Andrews, K. A., Stadnik, P., Joseph, A. P., Knox, R., Pittman, A., Clark, G., Baird, W., Bulstrode, N., Glover, M., Gordon, K., Hargrave, D., Huson, S. M., Jacques, T. S., James, G., Kondolf, H., Kangesu, L., Keppler-Noreuil, K. M., Khan, A., Lindhurst, M. J., Lipson, M., Mansour, S., O'Hara, J., Mahon, C., Mosica, A., Moss, C., Murthy, A., Ong, J., Parker, V. E., Rivière, J. B., Sapp, J. C., Sebire, N. J., Shah, R., Sivakumar, B., Thomas, A., Virasami, A., Waelchli, R., Zeng, Z., Biesecker, L. G., Barnacle, A., Topf, M., Semple, R. K., Patton, E. E., & Kinsler, V. A. (2018). Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy. The Journal of clinical investigation, 128(11), 5185. https://doi.org/10.1172/JCI124649
Al-Olabi, Lara, et al. "Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy." The Journal of clinical investigation vol. 128,11 (2018): 5185. doi: https://doi.org/10.1172/JCI124649
Al-Olabi L, Polubothu S, Dowsett K, Andrews KA, Stadnik P, Joseph AP, Knox R, Pittman A, Clark G, Baird W, Bulstrode N, Glover M, Gordon K, Hargrave D, Huson SM, Jacques TS, James G, Kondolf H, Kangesu L, Keppler-Noreuil KM, Khan A, Lindhurst MJ, Lipson M, Mansour S, O'Hara J, Mahon C, Mosica A, Moss C, Murthy A, Ong J, Parker VE, Rivière JB, Sapp JC, Sebire NJ, Shah R, Sivakumar B, Thomas A, Virasami A, Waelchli R, Zeng Z, Biesecker LG, Barnacle A, Topf M, Semple RK, Patton EE, Kinsler VA. Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy. J Clin Invest. 2018 Nov 01;128(11):5185. doi: 10.1172/JCI124649. Epub 2018 Nov 01. PMID: 30382944; PMCID: PMC6205386.
Copy
Download .nbib